Neurotrophin-3 Reduces Neuronal Loss in Pneumococcal Meningitis
Author Information
Author(s): Demel Cornelia, Hoegen Tobias, Giese Armin, Angele Barbara, Pfister Hans-Walter, Koedel Uwe, Klein Matthias
Primary Institution: Ludwig Maximilians University Munich
Hypothesis
Does systemically applied neurotrophin-3 (NT-3) improve hearing outcomes and neuron survival in pneumococcal meningitis?
Conclusion
Systemically applied NT-3 may help improve hearing outcomes and reduce neuronal loss after pneumococcal meningitis.
Supporting Evidence
- NT-3 treatment led to a significant decrease in spiral ganglion neuronal loss.
- Hearing thresholds improved in mice treated with NT-3 compared to placebo.
- The effects of NT-3 were comparable to those of dexamethasone.
- Systemically applied NT-3 reached the cochlea, indicating effective delivery.
Takeaway
This study found that a special protein called NT-3 can help protect hearing and brain cells in mice that got a serious infection.
Methodology
Mice were treated with NT-3 or dexamethasone after being infected with pneumococcal bacteria, and their hearing and neuron survival were assessed.
Potential Biases
Potential bias in the assessment of outcomes due to the nature of animal studies.
Limitations
The study was conducted in mice, and the effects in humans may differ; also, the long-term effects of NT-3 therapy are not fully understood.
Participant Demographics
C57BL/6 mice, aged 4-6 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website